Historical catalog analysis: CISA added this entry on January 21, 2026. The entry reflects catalog information retrieved on August 31, 2026, not a snapshot archived on the inclusion date. Check current vendor guidance before acting.
What the vulnerability is
CVE-2026-20045 is a code injection vulnerability (CWE-94) identified in several Cisco Unified Communications products. If exploited, this flaw could allow an attacker to obtain user-level access to the underlying operating system and subsequently elevate those privileges to root level.
Exposure and applicability
This vulnerability affects organizations utilizing the following Cisco products:
* Cisco Unified Communications Manager (Unified CM)
* Cisco Unified Communications Manager Session Management Edition (Unified CM SME)
* Cisco Unified Communications Manager IM & Presence Service (Unified CM IM&P)
* Cisco Unity Connection
* Cisco Webex Calling Dedicated Instance
For U.S. healthcare providers, these systems often serve as the backbone for clinical communication, patient care coordination, and emergency alerting. A compromise of this infrastructure could lead to unauthorized access to system configurations or a disruption in the ability of clinical staff to communicate during critical care events.
Remediation priorities
Based on our analysis, healthcare IT and security leaders should prioritize the following actions to reduce risk:
- Inventory and Version Audit: Identify all instances of the affected Cisco products across the environment. This is a prerequisite for determining which systems require patching or mitigation.
- Apply Vendor Mitigations: Deploy the specific mitigations provided by Cisco. For cloud-based services, follow applicable guidance such as BOD 22-01 where relevant.
- Evaluate Product Viability: In cases where mitigations are unavailable for a specific legacy version, evaluate whether to discontinue use of the product to eliminate the attack surface.
How to validate remediation
To verify that exposure has been reduced, administrators should:
* Confirm through system logs or management consoles that the vendor-recommended patches or configuration changes have been successfully applied to all identified assets.
* Cross-reference current software versions against the list of fixed releases provided in the official Cisco security advisory.
Note: A version check indicates a patch is present but does not guarantee the system is secure from all possible attack vectors.
Limits and open questions
It remains unknown whether this vulnerability has been utilized in ransomware campaigns. While CISA added this to the Known Exploited Vulnerabilities catalog on January 21, 2026, the original disclosure date was not specified in the source data. Furthermore, while federal agencies have a specific CISA due date for remediation, this does not constitute a legal requirement for private healthcare entities, though it serves as a high-priority indicator of risk.
Source and editorial note
CVE-2026-20045: Cisco Unified Communications Products Code Injection Vulnerability · Source date: January 21, 2026 · Retrieved August 31, 2026.
Material facts are tied to the cited primary source. Recommendations are independent defensive analysis unless attributed to the source. Confirm consequential decisions against current authoritative guidance.
Archive date: January 24, 2026. The displayed post date is assigned three days after the source date to organize this retrospective archive; it does not mean this site published the analysis then. First published by this site: September 21, 2026 at 01:13 UTC.
Request a healthcare security assessment
Turn healthcare security intelligence into action.
Discuss your environment, priorities, and the evidence needed to validate safeguards.
Request a healthcare assessment ↗